Clinical Trial Update: Aquacel Hypersensitivity Dressing in TJAs [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Aquacel Hypersensitivity Dressing in total joint arthroplasty has completed, focusing on allergic skin reactions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Contact Dermatitis
• Dermatitis

Drugs mentioned

• Aquacel Hypersensitivity Dressing

Snippet

Sponsor: Rush University Medical Center | Conditions: Contact Allergic Dermatitis, Adverse Skin Reaction | Phase 4 | Status: COMPLETED